SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
21/08/26	₩2,020.00	-4.27%	456,037
20/08/26	₩2,110.00	+1.44%	223,172
19/08/26	₩2,080.00	-2.80%	537,420
18/08/26	₩2,140.00	-2.28%	491,692
14/08/26	₩2,190.00	-1.35%	668,247

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 21/08/2026			5-day change	1st Jan Change
2,020.00 ^KRW	-4.27%		-9.01%	+18.06%

08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI

Market Cap	121B 87.71M 75.07M 70.21M 64.26M 121M 8.39B 122M 830M 323M 4.21B 329M 322M 13.96B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	129B 92.89M 79.51M 74.36M 68.06M 128M 8.88B 129M 879M 343M 4.46B 349M 341M 14.79B	EV / Sales 2025	3.42x	EV / Sales 2026	9.89x
Free-Float	76.26%	Yield 2025 *	-	Yield 2026	-

08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
06-18	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-29	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
05-27	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
05-20	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
05-13	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
04-13	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
02-25	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
02-13	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
27/10/25	PineTree Therapeutics, Inc. announced that it has received $47.000004 million in funding from a group of investors	CI
21/08/25	PineTree Therapeutics, Inc. announced that it expects to receive $48.00006 million in funding	CI

1 day	-4.27%
1 week	-9.01%
Current month	+14.97%
1 month	+16.97%
3 months	-33.99%
6 months	-48.60%
Current year	+18.06%

SV Investment Corporation Share Price

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation: SV Investment Corporation

Chart: SV Investment Corporation

Latest news : SV Investment Corporation

Quotes and Performance

Course Extremes

Managers and Directors: SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	1,940	2,270
1 month	1,439	2,560
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Seong-Ho Park CEO	Chief Executive Officer	57	-
Won-Ho Hong CEO	Chief Executive Officer	61	29/09/2019
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	29/06/2023

Director	Title	Age	Since
Won-Ho Hong BRD	Director/Board Member	61	29/09/2019
Seong-Ho Park BRD	Director/Board Member	57	-
Ji-Hwa Ryu BRD	Director/Board Member	56	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	-4.27%	-9.01%	+18.13%	+5.21%	91.08M
BB BIOTECH AG	+1.45%	+4.10%	+74.69%	+38.02%	3.8B
HERCULES CAPITAL, INC.	+0.59%	+1.18%	-10.45%	+4.39%	3.14B
HBM HEALTHCARE INVESTMENTS AG	-2.05%	-3.83%	+38.82%	+27.95%	2.02B
MOLTEN VENTURES PLC	+0.07%	-0.73%	+88.09%	+198.59%	1.46B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	735M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	-7.82%	-17.47%	+140.86%	+192.34%	600M
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.33%	-7.05%	413M
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-40.68%	-75.18%	393M
PEMBROKE VCT PLC	0.00%	0.00%	+0.54%	-13.02%	373M
Average	-1.20%	-2.43%	+30.49%	+36.42%	1.3B
Weighted average by Cap.	-0.13%	-0.31%	+40.37%	+44.40%

	2025	2026
Net sales	19.98B 14.43M 12.35M 11.55M 10.57M 19.84M 1.38B 20.1M 137M 53.22M 693M 54.14M 52.96M 2.3B	20.52B 14.81M 12.68M 11.86M 10.85M 20.37M 1.42B 20.64M 140M 54.64M 711M 55.58M 54.37M 2.36B
Net income	-5.23B -3.78M -3.23M -3.02M -2.77M -5.2M -361M -5.26M -35.75M -13.93M -181M -14.17M -13.87M -601M	-1B -723K -619K -579K -530K -994K -69.12M -1.01M -6.84M -2.67M -34.7M -2.71M -2.65M -115M
Net Debt	-1.04B -751K -643K -602K -551K -1.03M -71.86M -1.05M -7.11M -2.77M -36.07M -2.82M -2.76M -120M	7.18B 5.18M 4.44M 4.15M 3.8M 7.13M 496M 7.22M 49.05M 19.12M 249M 19.45M 19.02M 825M